A federal district judge in Illinois has dismissed a Chicago hospital’s apparently successful lawsuit challenging its termination from the 340B [...] …
Year: 2023
A group of Senate Republicans recently urged federal regulators to withdraw a plan to change the definition of a drug’s [...] …
An influential drug industry trade group recently urged a federal judge to rule on its suit against Louisiana’s 340B contract [...] …
The Arkansas Insurance Department (AID) recently asked a federal district judge to dismiss Novo Nordisk’s lawsuit that challenges Arkansas’ state [...] …
A federal district judge in South Carolina late today struck down the 340B program’s patient definition, as federal regulators described [...] …
Medicare Part B will continue to pay hospitals for 340B drugs at the rate of average sales price (ASP) plus [...] …
Medicare issued a final rule today to implement a $9 billion lump sum payment to 340B hospitals and to cut [...] …
Forty-four health systems and hospitals sued federal healthcare agencies over their recent decision to end a 340B COVID-related registration flexibility [...] …
Organon, a Merck spinoff with a focus on women’s health, yesterday became the sixth drugmaker to loosen or end its [...] …
SPONSORED CONTENT
The Centers for Medicare & Medicaid Services (CMS) has issued a final rule that goes into effect on January 1, 2024 that changes the way Direct and Indirect Remuneration (DIR) fees are collected. To understand the impact
…